other material
confidence high
sentiment neutral
materiality 0.45
Bluejay Diagnostics shareholders approve reverse stock split (1:20-1:50 ratio)
Bluejay Diagnostics, Inc.
- 6,958,210 shares present (42.0% quorum) at October 23, 2024 special meeting.
- Proposal passed: 5,358,166 For, 1,487,443 Against, 112,601 Abstain.
- Board retains discretion to select exact ratio (1:20 to 1:50) and timing.
- No decision yet on whether or when to implement the reverse stock split.